Generation of A New Therapeutic D-Peptide That Induces the Differentiation of Acute Myeloid Leukemia Cells Through A TLR-2 Signaling Pathway
Authors:
- Hui ZhangHZHui Zhang
- Fei YuFYFei Yu
- Jun LiuJLJun Liu
Preprint
- 11 January 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Acute myeloid leukemia (AML) is caused by clonal disorders of hematopoietic stem cells. Differentiation therapy is emerging as an important treatment modality for leukemia, given its less toxicity and wider applicable population, but the arsenal of differentiation-inducing agents is still very limited. In this study, we adapted a competitive peptide phage display platform to search for candidate peptides that could functionally induce human leukemia cell differentiation. A monoclonal phage (P6) and the corresponding peptide (pep-P6) was identified. Both L- and D-chirality of pep-P6 showed potent efficiency in inducing THP-1 cells differentiation, driving their morphologic maturation and upregulating the expression of macrophage markers and cytokines including CD11b, CD14, IL-6, IL-1β and TNF-α. In the THP-1 xenograft animal model, administration of D-pep-P6 was effective in inhibiting tumor growth. Importantly, exposure to D-pep-P6 induced the differentiation of primary human leukemia cells isolated AML patients in a similar manner to the THP-1 cells. Further mechanical study suggested that D-pep-P6 induced human leukemia cell differentiation by directly activating a TLR-2 signaling pathway. These findings identify a novel D-peptide that may promote leukemia differentiation therapy.Keywords
All Related Versions
- Version 1, 2023-01-11, Research Square
- Published version: Cell Death Discovery, 10 (1), 1.
This publication has 29 references indexed in Scilit:
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic ApplicationsACS Applied Materials & Interfaces, 2020
- Acute Myeloid Leukemia: from Mutation Profiling to Treatment DecisionsCurrent Hematologic Malignancy Reports, 2019
- Acute myeloid leukemia: 2019 update on risk‐stratification and managementAmerican Journal of Hematology, 2018
- The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic LeukemiaArchivum Immunologiae et Therapiae Experimentalis, 2016
- Novel analogs of 1,25-dihydroxyvitamin D2 combined with a plant polyphenol as highly efficient inducers of differentiation in human acute myeloid leukemia cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2016
- The role of TLR8 signaling in acute myeloid leukemia differentiationLeukemia, 2014
- Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsAnnals of Hematology, 2012
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemiaNature Medicine, 2012
- Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophagesMolecular and Cellular Biochemistry, 2009
- Phage display-derived peptides as therapeutic alternatives to antibodiesDrug Discovery Today, 2004